Latest Market Report | PD L1 Biomarker Testing Market Analys

The global PD L1 biomarker testing market is expected to touch US$ 14.2 billion by 2030, with an annual growth rate of more than 16.5% says RationalStatWilmington, Delaware, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Global PD L1 Biomarker Testing Market is valued at US$ 4.9 billion in 2023 and is expected to grow at a significant CAGR of over 16.5% over the forecast period of 2023-2030, according to the published market report by RationalStat Market Definition, Market Scope, and Report Overview Programm

Related Keywords

Mexico , United States , South Korea , Brazil , United Arab Emirates , France , Hungary , Thailand , Nigeria , Poland , Canada , Saudi Arabia , South Africa , China , Indonesia , Australia , United Kingdom , India , Spain , Malaysia , Japan , Russia , Philippines , Italy , Turkey , Delaware , Germany , Vietnam , Republic Of , America , Asia Pacific , Leica Biosystems , Bristol Myers Squibb , Kimberly Shaw , Research Methodology , Astrazeneca , Abbott Laboratories , Year Market , Genentech , Market Scope , North America , Latin America , Western Europe , Eastern Europe , Middle East , Production Levels , Capacity Utilization , Testing Market , Market Share , Market Structure , Thermo Fisher Scientific , Bio Rad Laboratories , Testingmarket Value , Testing Market Value , Arab Emirates , Questions Answered , Testing Report , Key Insights , Market Data , Kingdom Phone , Market Intelligence , Market Sizing ,